INT152275

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.06
First Reported 2007
Last Reported 2008
Negated 0
Speculated 0
Reported most in Abstract
Documents 2
Total Number 2
Disease Relevance 1.15
Pain Relevance 0.37

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

peptidase activity (HGFAC) extracellular space (HGFAC) extracellular region (HGFAC)
cytoplasm (HGFAC)
Anatomy Link Frequency
leukocytes 1
HGFAC (Homo sapiens)
Pain Link Frequency Relevance Heat
Pain 1 97.24 Very High Very High Very High
bradykinin 1 94.12 High High
Inflammation 7 86.36 High High
addiction 1 5.00 Very Low Very Low Very Low
headache 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pain 1 97.24 Very High Very High Very High
Increased Venous Pressure Under Development 3 95.52 Very High Very High Very High
INFLAMMATION 6 86.36 High High
Anaemia 26 75.00 Quite High
Renal Disease 1 75.00 Quite High
Chronic Renal Failure 16 71.64 Quite High
Cancer 5 5.00 Very Low Very Low Very Low
Cv Unclassified Under Development 5 5.00 Very Low Very Low Very Low
Cardiovascular Disease 3 5.00 Very Low Very Low Very Low
Heart Disease 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The urokinase plasminogen activator and its cellular receptor, expressed on the surface of human leukocytes, provide a functional unit that, by regulating interaction of leukocytes with extracellular matrix, as well as its degradation, is critical for the migration of leukocytes and for their movement in the damaged tissues.
Gene_expression (expressed) of activator in leukocytes
1) Confidence 0.06 Published 2008 Journal Front. Biosci. Section Abstract Doc Link 18508538 Disease Relevance 0.67 Pain Relevance 0.37
Recently developed and undergoing phase III clinical trials is the third-generation ESA, Continuous Erythropoiesis Receptor Activator (CERA), which has a methoxy-polyethylene glycol polymer chain integrated and has a longer elimination half-life than the first- and second-generation ESAs.
Gene_expression (generation) of Activator
2) Confidence 0.02 Published 2007 Journal International Journal of Nanomedicine Section Abstract Doc Link PMC2673829 Disease Relevance 0.48 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox